Pfizer Ireland Pharmaceuticals · 66-66 · IRELAND
For Pfizer Ireland Pharmaceuticals, import alert is 66-66; country is IRELAND; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; product is Levobunolol; product code is 60 X - S 26 Levobunolol Hydrochloride (Anti-Adrenergic), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is Loughbeg Drug Product Plant , Ringaskiddy, County Cork IRELAND, verified against its source on 2026-09-30.
- Firm
- Pfizer Ireland Pharmaceuticals verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- IRELAND verified
- Address
- Loughbeg Drug Product Plant , Ringaskiddy, County Cork IRELAND verified
- Date published
- 09/30/2009 verified
- Product code
- 60 X - S 26 Levobunolol Hydrochloride (Anti-Adrenergic), Active Pharm Ingred/Chems for Further Manuf verified
- Product
- Levobunolol verified
- FDA notes
- 11/2/2000 verified
What the source says
Pfizer Ireland Pharmaceuticals Date Published : 09/30/2009 Loughbeg Drug Product Plant , Ringaskiddy, County Cork IRELAND
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
60 X - S 26 Levobunolol Hydrochloride (Anti-Adrenergic), Active Pharm Ingred/Chems for Further Manuf Date Published: 04/02/2019 Desc: Levobunolol Notes: 11/2/2000
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html